Trial Radar AI | ||
|---|---|---|
Clinical Trial NCT06843512 for Weight Loss, Food Selection is recruiting. See the Trial Radar Card View and AI discovery tools for all the details. Or ask anything here. | ||
One study matched filter criteria
Card View
Back to Search
Penn State UniversityIdentifying Changes in Food Behaviors Associated With Beginning GLP-1 Medication 25
Clinical Trial NCT06843512 is an observational study for Weight Loss, Food Selection that is recruiting. It started on 15 July 2025 with plans to enroll 25 participants. Led by Penn State University, it is expected to complete by 1 December 2026. The latest data from ClinicalTrials.gov was last updated on 10 September 2025.
Brief Summary
In recent years, GLP-1 medications have become a widely employed approach by physicians to address weight concerns in patients and lead to weight loss. Little is known, however, about how these medications may alter an individual's attitude towards food, food reactivity, or the specific types and amounts of foods an individual will choose. The purpose of this study is to observe the changes an individual experiences ...Show More
Official Title
Exploring the Influence of GLP-1 Medication on Food Attitudes and Selection in a Virtual Reality Buffet
Conditions
Weight LossFood SelectionOther Study IDs
- STUDY00026642
NCT ID Number
Start Date (Actual)
2025-07-15
Last Update Posted
2025-09-10
Completion Date (Estimated)
2026-12
Enrollment (Estimated)
25
Study Type
Observational
Status
Recruiting
Keywords
GLP-1
Weight Loss
Virtual Reality
Food behavior
Weight Loss
Virtual Reality
Food behavior
Arms / Interventions
| Participant Group/Arm | Intervention/Treatment |
|---|---|
N/A | GLP-1 Medication Initiation One visit before starting GLP-1 medication and one visit 3 months after. No other changes administered between visits. |
Primary Outcome Measures
Secondary Outcome Measures
| Outcome Measure | Measure Description | Time Frame |
|---|---|---|
Change from Baseline in Total Weight of Food Selected in the VR Buffet at 3 Months | Baseline and 3 months | |
Change from Baseline in Total Calories of Food Selected in the VR Buffet at 3 Months | Baseline and 3 months | |
Change from Baseline in Energy Density of Food Selected in the VR Buffet at 3 Months | Baseline and 3 months | |
Change from Baseline in Variety of Food Selected in the VR Buffet at 3 Months | Baseline and 3 months |
| Outcome Measure | Measure Description | Time Frame |
|---|---|---|
Change in Baseline Weight Watchers Food Noise Score at 3 Months | Based on participant's answers to the WW Food Noise questionnaire; Scale of 1-5, 1 being strongly disagree and 5 being strongly agree; Higher scores mean more food noise | Baseline and 3 months |
Change in Baseline 9-question External Food Cue Responsiveness Questionnaire Score at 3 Months | Answers are on a 1-4 scale with 1 being "Rarely" and 4 being "A lot"; higher scores suggest more external food cue reactivity | Baseline and 3 months |
Change in Baseline Adult Eating Behavior Score at 3 Months | Answers on a 1-5 scale with 1 being "Strongly disagree" and 5 being "Strongly agree"; 8 subscales, high scores indicate greater expression of subscale measure | Baseline and 3 months |
Change in Baseline Three-Factor Eating Questionnaire Score at 3 Months | Rated on a scale of 1-4 with 1 being "Definitely false" and 4 being "Definitely true"; 3 subscales, higher scales on each means greater expression of that behavior | Baseline and 3 months |
Change in Baseline General Food Craving-Trait Scale Score at 3 Months | Rated on a 0-5 scale with 0 being "Never/not applicable" and 5 being "Always"; higher scores mean more food dependent | Baseline and 3 months |
Change in Baseline Buffet Food Liking Scores at 3 Months | Rated on a 0-100 scale with 0 being "Dislike extremely" and 100 being "Like extremely"; high scores mean greater liking of the food | Baseline and 3 months |
Participation Assistant
Eligibility Criteria
Eligible Ages
Adult, Older Adult
Minimum Age
18 Years
Eligible Sexes
All
- Adults (18+) with overweight or obesity (BMI >25 kg/m2)
- Not currently taking an incretin-based medication at baseline
- Recently (within two weeks) prescribed a GLP-1, can be included if they have a obesity-related co-occurring condition (diabetes, hypertension, cardiovascular disease, dyslipidemia)
- Have had no prior diagnosis of cognitive or physical disability, dyslexia, or epilepsy.
- Fluent in English
- Adults (18+) without overweight or obesity
- <18 years of age at time of testing
- Adults not taking a GLP-1 Medication
- Adults taking a compound GLP-1
- Adults on GLP-1 medication for longer than 2 weeks at baseline
- Have had a prior diagnosis of cognitive or physical disability, dyslexia, or epilepsy.
- Not fluent in English
Penn State University91 active studies to exploreStudy Responsible Party
Travis Masterson, Principal Investigator, Assistant Professor and Director of the Health, Ingestive Behavior, and Technology Lab, Penn State University
Study Central Contact
Contact: Christina M Blackmon, 425-499-8049, [email protected]
1 Study Locations in 1 Countries
Pennsylvania
Health, Ingestive Behavior, and Technology Laboratory of Pennsylvania State University, State College, Pennsylvania, 16802, United States
Christina M Blackmon, Contact, 425-499-8049, [email protected]
Recruiting